semaglutide anaesthesia New Study Recommends Stopping GLP-1 Agonists 14 Days Before Total Joint Arthroplasty to Reduce Anesthesia Risks A very important and practice-changing
Description
Beyond weight loss, the 7.2mg dose of semaglutide brought measurable improvements in metabolic health
The review evaluates these drugs across diverse patient populations, including those with clinically established T2D, obesity, CVD, and CKD
Apply light pressure if needed
about Wegovy and whether it can be used during pregnancy
Improved insulin sensitivity and metabolic stability
In an interview with HCPLive, Mark Taylor, MD, consultant psychiatrist at The Edinburgh Practice and professor at Griffith University, discussed a Swedish registry study that compared periods when patients were on GLP-1 therapy versus off treatment, effectively using each patient as their own control
